Skip to main content
. 2023 Jun 26;13(13):2167. doi: 10.3390/diagnostics13132167

Figure 3.

Figure 3

Brain injury biomarkers (sNfL/sGFAP) before and after a SARS-CoV-2 infection and at different clinical groups. (a) sNfL before and after infection (n = 142), (b) sGFAP before and after infection (n = 140). The Wilcoxon test was used to assess group differences before and after an infection. Complete cases are represented in the dot plot. The central horizontal line represents the median with the interquartile range (IQR).